Branko Calukovic

Specialist in Internal Medicine with 6+ years of oncology experience at University Hospital Tübingen. Experienced in inpatient/outpatient care, early-phase trials, tumor boards, and translational research. Sub-Investigator on Phase I–III immunotherapy and targeted therapy studies (NSCLC, sarcoma, NET). Holds a doctorate in molecular sarcoma profiling, GCP certification, scientific publications, and fluency in English and German. Skilled in clinical development and safety oversight.

* Active involvement in Phase I–III clinical trials across solid tumor indications * Responsible for patient screening, consent, enrollment, and safety follow-up * Expertise in adverse event evaluation, causality assessment, and CTCAE grading * Ensured protocol adherence, data integrity, and compliance with GCP and regulatory standards * Collaborated closely with sponsors, CRAs, and study coordinators to maintain high-quality trial conduct * Contributed to investigator-initiated and translational research p

* Broad clinical training in Internal Medicine, including ICU and Emergency Medicine * In-depth experience in Medical Oncology, with focus on sarcoma, neuroendocrine, and thoracic malignancies * Skilled in diagnostic evaluation, therapy planning, and complex patient management * Active participation in multidisciplinary tumor boards and evidence-based clinical decision-making * Strong foundation in patient communication, ethical medical practice, and team-based care * Dedicated to medical education and ment